Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
Quick facts
Marketed products
- infliximab+azathioprine · Immunology / Gastroenterology
Infliximab blocks TNF-α to reduce inflammation while azathioprine suppresses immune cell proliferation, providing dual immunosuppression for inflammatory bowel disease. - methylprednisolone or budesonide · Immunology / Gastroenterology
Both methylprednisolone and budesonide are corticosteroids that suppress immune and inflammatory responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: